Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Helen McShane

Cellular Immunology and Vaccine Development

Helen McShane is currently a Professor of Vaccinology at Oxford University, Wellcome Senior Clinical Research Fellow, Deputy Head of Division (Translation and Personnel), Oxford NIHR BRC Director and Honorary Consultant physician HIV medicine. Helen obtained an intercalated BSc in 1988, followed by a degree in medicine in 1991 (both University of London). In 1997 she was awarded an MRC Clinical Training Fellowship to undertake a PhD with Adrian Hill in Oxford, and was later awarded a PhD in 2001 (University of London). In 2001 she was awarded a Wellcome Clinician Scientist Fellowship, allowing her to complete her clinical training and subsequently awarded a CCST in HIV and GU medicine in 2003. In 2005, she was awarded a Wellcome Senior Clinical Research Fellowship; this fellowship was renewed in 2010.Helen has led the TB vaccine research group at Oxford University for 15 years and notably headed the development of MVA85A; one of the most clinically advanced new TB vaccine candidates and the first to enter human efficacy testing. She collaborates with several research groups in Africa in the conduct of clinical trials and current interests are in immunomonitoring in clinical trials, the development of human mycobacterial challenge models and aerosol delivery of vaccines